Department of Obstetrics & Gynecology (S.H.K., H.J.I., Y.S.O., H.D.C., C.-H.K., B.M.K.), University of Ulsan College of Medicine, Asan Medical Center, Seoul 138-736, Korea; Department of Obstetrics & Gynecology (S.Cho.), Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul 135-720, Korea; Asan Institute for Life Sciences (S.-H.H.), University of Ulsan College of Medicine, Seoul 138-736, Korea; Department of Laboratory Medicine (S.Chu.), University of Ulsan College of Medicine, Asan Medical Center, Seoul 138-736, Korea; and Center for Life & Environmental Science (H.I.), Seegene Medical Foundation, Seoul 138-828, Korea.
J Clin Endocrinol Metab. 2015 Dec;100(12):E1502-11. doi: 10.1210/jc.2015-2478. Epub 2015 Oct 6.
Although phthalates were shown to have several negative effects on reproductive function in animals, its role in the pathogenesis of endometriosis remains to be elucidated.
We aimed to investigate the in vitro and in vivo effects of di-(2-ethylhexyl)-phthalate (DEHP) and to compare the urinary levels of several phthalate metabolites between women with and without endometriosis.
For experimental studies, we used endometrial cell culture and nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mouse models. We also performed a prospective case-control study for human sample analyses.
The study was conducted at an academic center.
The activities of matrix metalloproteinase (MMP)-2 and 9, cellular invasiveness, phosphorylation of extracellular signal-regulated kinase (Erk), and expression of p21-activated kinase 4 were analyzed in endometrial cells treated with DEHP. The implant size was compared between NOD/SCID mice fed with and without DEHP. Urinary concentrations of several phthalate metabolites were compared between women with and without endometriosis.
In vitro treatment of endometrial cells with DEHP led to significant increases of MMP-2 and 9 activities, cellular invasiveness, Erk phosphorylation, and p21-activated kinase 4 expression. The size of the endometrial implant was significantly larger in the NOD/SCID mice fed with DEHP compared with those fed with vehicle. The urinary concentration of mono (2-ethyl-5-hydroxyhexyl) phthalate, mono (2-ethyl-5-oxohexyl) phthalate, and mono (2-ethyl-5-carboxyphentyl) phthalate were significantly higher in women with endometriosis compared with controls.
These findings strongly suggest that exposure to phthalate may lead to establishment of endometriosis by enhancing invasive and proliferative activities of endometrial cells.
尽管邻苯二甲酸酯已被证明对动物的生殖功能有多种负面影响,但它在子宫内膜异位症发病机制中的作用仍有待阐明。
本研究旨在探讨邻苯二甲酸二(2-乙基己基)酯(DEHP)的体外和体内作用,并比较子宫内膜异位症患者和非患者的几种邻苯二甲酸代谢物的尿水平。
对于实验研究,我们使用了子宫内膜细胞培养和非肥胖糖尿病/严重联合免疫缺陷(NOD/SCID)小鼠模型。我们还进行了一项前瞻性病例对照研究,以分析人类样本。
本研究在一个学术中心进行。
用 DEHP 处理的子宫内膜细胞的基质金属蛋白酶(MMP)-2 和 9 的活性、细胞侵袭性、细胞外信号调节激酶(Erk)的磷酸化和 p21 激活激酶 4 的表达进行了分析。比较了给予和未给予 DEHP 的 NOD/SCID 小鼠的植入物大小。比较了子宫内膜异位症患者和非患者的几种邻苯二甲酸代谢物的尿浓度。
体外用 DEHP 处理子宫内膜细胞可显著增加 MMP-2 和 9 的活性、细胞侵袭性、Erk 磷酸化和 p21 激活激酶 4 的表达。与给予载体的 NOD/SCID 小鼠相比,给予 DEHP 的 NOD/SCID 小鼠的子宫内膜植入物明显更大。与对照组相比,子宫内膜异位症患者的尿中单(2-乙基-5-羟基己基)邻苯二甲酸、单(2-乙基-5-氧代己基)邻苯二甲酸和单(2-乙基-5-羧基苯)邻苯二甲酸浓度明显更高。
这些发现强烈表明,暴露于邻苯二甲酸可能通过增强子宫内膜细胞的侵袭性和增殖活性导致子宫内膜异位症的建立。